Diabetes technology generates vital health data, but healthcare professionals (HCP) and patients must navigate multiple platforms to access it. We developed a digital health platform, co-designed with patients and families living with type 1 diabetes (T1D) and their HCPs, that aim to support a collaborative care experience through shared access to diabetes data, clinical recommendations, and resources. We describe caregivers’ views on the platform’s impact on clinic visits and child self-management in children with T1D. A six-month observational pilot study at BC Children’s Hospital Diabetes Clinic in British Columbia, Canada, gathered data through surveys and interviews. Surveys were administered to caregivers and HCPs at different time points throughout the study; 18 qualitative interviews were conducted with caregivers at the conclusion of the study. Quantitative data were summarized descriptively. Interview data were transcribed, coded using open and systematic coding, and subsequent inductive thematic analysis. Eighteen caregivers completed the surveys, and 11 HCP participants submitted 41 surveys (approximately 3-4 each) after using the platform. Most caregivers (61%; 11/18) found the platform helpful, and 56% (10/18) reported that using the platform made their clinical visits and recommendations more personalized. Nearly all HCPs (90%; 37/41) were satisfied with the platform’s ability to support clinical visits. Themes identified from caregiver qualitative interviews revealed that (1) the platform provided a convenient connection that improved preparedness and empowered caregivers in managing their child’s T1D; (2) the platform’s value was driven by the healthcare team’s usage of it; and (3) caregivers felt hopeful that the platform could better support their child’s T1D management. The platform could foster a collaborative and personalized care experience that enables caregivers to engage in diabetes self-management and feel connected to their healthcare team. These results will guide the future development, evaluation, and implementation of the platform.

Author Summary Managing type 1 diabetes (T1D) involves keeping track of a lot of health information, like blood sugar levels, insulin doses, and food intake. Right now, families and healthcare providers often need to use several different apps or systems to access this information, which can be confusing and hard to manage.

To make this easier, we created a new digital platform that puts all the important diabetes data in one place. We designed it together with families of children with T1D and their healthcare providers, so it could truly meet their needs. The goal was to help families and doctors work together more easily by sharing information, treatment recommendations, and helpful resources.

We tested the platform during a six-month pilot study at BC Children’s Hospital Diabetes Clinic in British Columbia, Canada. We asked parents and caregivers, as well as healthcare professionals, to share their thoughts through surveys and interviews. In total, 18 caregivers completed surveys, and 11 healthcare providers filled out 41 surveys. At the end of the study, we also interviewed 18 caregivers to hear more about their experience using the platform.

The results were promising. Most caregivers (61%) said the platform was helpful in managing their child’s diabetes. Over half (56%) felt that their visits with their doctor and diabetes team became more personal and tailored to their child’s specific needs. Nearly all of the healthcare providers (90%) said the platform helped improve their clinical visits.

Caregivers also shared some deeper insights during interviews. They said the platform helped them feel more prepared for appointments and more confident in managing their child’s diabetes. They also noted that the platform worked best when their healthcare team actively used it. Many felt hopeful that this kind of tool could make a big difference in their child’s day-to-day diabetes care.

In short, this digital platform shows real potential to improve the way families and healthcare teams manage type 1 diabetes together. It could lead to more personalized care, improved communication and connection, and better support for both children and their caregivers. These early results will help us improve the platform and guide how it’s used in the future.

Shazhan Amed holds a BC Children's Hospital Research Institute Salary Award. SA has participated on advisory boards for Dexcom, Abbott, Novo Nordisk, Eli Lilly, Sanofi, and Insulet. Matthias Gorges holds a Michael Smith Health Research BC scholar award (SCH-2020-0494). Elizabeth Borycki holds a Michael Smith Health Research BC Health Professional Investigator award. Susan Pinkney, Fatema S Abdulhussein, Anila Virani, Carlie Zachariuk, Sukhpreet K Tamana, Shruti Muralidharan, Bonnie Barrett, Tibor van Rooij, Andre Kushniruk, Holly Longstaff, Alice Virani, Wyeth W Wasserman report no conflicts of interest.

This study was funded by the University of British Columbia's Office of the Vice President of Research and Innovation [Award Number: AWD-015766], in collaboration with Canada's Digital Technology Supercluster, MITACS Inc., and industry partners including IDENTOS, Careteam Technologies, and Smile Digital Health.

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

After receiving a waiver from the Children & Women’s Research Ethics Board at the University of British Columbia, this study was approved under the Quality Improvement category by the Data Collections and Solutions Steering Committee and the Provincial Health Services Authority Privacy Office through the completion of a Privacy Impact Assessment. Informed consent was obtained from each parent/guardian and healthcare professional for their participation. Additionally, assent was obtained from minors (aged over 7 years).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

The authors confirm that the data supporting the findings of this study are available within the article [and/or] its supplementary materials.